4.6 Review

COVID-19 and cardiovascular diseases

期刊

JOURNAL OF MOLECULAR CELL BIOLOGY
卷 13, 期 3, 页码 161-167

出版社

OXFORD UNIV PRESS
DOI: 10.1093/jmcb/mjaa064

关键词

COVID-19; cardiovascular diseases; SARS-CoV-2; ACE2; systemic inflammation

资金

  1. National Key Research and Development Program of China [2018YFA0800200, 2018YFA0801200]
  2. Strategic Priority Research Program of the Chinese Academy of Sciences [XDA16010207]
  3. National Natural Science Foundation of China [31830061, 31425016, 81530004]
  4. State Key Laboratory of Membrane Biology of China

向作者/读者索取更多资源

COVID-19, caused by SARS-CoV-2, not only affects the lungs but also has severe implications in the cardiovascular system. Understanding the mechanisms of cardiovascular injury in COVID-19 patients is crucial for appropriate identification and treatment.
The coronavirus disease 2019 (COVID-19) remains a global public health emergency. Despite being caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), besides the lung, this infectious disease also has severe implications in the cardiovascular system. In this review, we summarize diverse clinical complications of the heart and vascular system, as well as the relevant high mortality, in COVID-19 patients. Systemic inflammation and angiotensin-converting enzyme 2-involved signaling networking in SARS-CoV-2 infection and the cardiovascular system may contribute to the manifestations of cardiovascular diseases. Therefore, integration of clinical observations and experimental findings can promote our understanding of the underlying mechanisms, which would aid in identifying and treating cardiovascular injury in patients with COVID-19 appropriately.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据